Macrogen Selects N-of-One to Provide Patient-specific Interpretation for the Launch of New Clinical Next-Generation Sequencing Panels

LEXINGTON, Mass.--(BUSINESS WIRE)--N-of-One announced that Macrogen Corp. has selected N-of-One to provide high-quality clinical interpretation for its clinical next-generation sequencing (NGS) panels used for cancer patients.